1. Long-term survival and complications in patients with mechanical aortic valves without anticoagulation A follow-up study from 1 to 15 years
- Author
-
Andersen Pv and Alstrup P
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,Aortic valve ,medicine.medical_specialty ,Time Factors ,Adolescent ,Aortic valve replacement ,Postoperative treatment ,Thromboembolism ,Long term survival ,medicine ,Humans ,In patient ,Aged ,Retrospective Studies ,business.industry ,Follow up studies ,Mean age ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Surgery ,Survival Rate ,medicine.anatomical_structure ,Aortic Valve ,Heart Valve Prosthesis ,Female ,Cardiology and Cardiovascular Medicine ,Complication ,business ,Follow-Up Studies - Abstract
In aortic valve replacement most centres prefer to use a mechanical valve for younger patients without special bleeding risks and treat the patient with lifelong anticoagulation. However, a few patients do not receive anticoagulation at all or have this withdrawn after some time. We examined the prognosis of 43 patients, 37 men and 6 women (mean age 52 years), who were treated with anticoagulation for approximately only 1 year (mean 13 months; range 4-35 months) after isolated aortic valve replacement with a mechanical valve. The mean follow-up period was 7 years and 3 months (1.5 months to 15 years and 10 months). After 5 and 10 years, 70% and 59%, respectively, were free of thromboembolic events, 65% and 55%, respectively, were free of valve-related events, and 87% and 83%, respectively, had survived. These figures correspond to linearized rates of thromboembolic events of 5.2%/pt-yr, valve-related events of 6.2%/pt-yr and death of 2.9%/pt-yr. We conclude that the best postoperative treatment in isolated aortic valve replacement with a mechanical valve is lifelong anticoagulation.
- Published
- 1992
- Full Text
- View/download PDF